Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma

BACKGROUND: Repetitive long-term Vaccinia Melanoma Cell Lysate (VMCL) vaccination schedules have proved clinically effective in producing Complete Responses and strong durable survivals for up to 6.1 years in a previous study of patients with advanced Stage IV and Stage IIIc melanoma. These studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Coventry, Brendon J, Lilly, Carrie A, Hersey, Peter, Michele, Antonio, Bright, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950896/
https://www.ncbi.nlm.nih.gov/pubmed/27437102
http://dx.doi.org/10.1186/2051-1426-2-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950896/
https://www.ncbi.nlm.nih.gov/pubmed/27437102
http://dx.doi.org/10.1186/2051-1426-2-9

Ejemplares similares